|
|
We are a healthcare company that provides cardiovascular disease (CVD) management, with a unique focus on the secondary prevention market. Through our combination of proprietary lipid testing technology, esoteric testing capability, advanced therapy guidelines, sophisticated informatic tools, and patient support services, we are providing physicians and patients a viable disease management offering for CVD.
|
Unlike other lipid testing companies that are focused on the primary screening market for CVD, our proprietary testing technology and facilitating esoteric testing capability allow for the ongoing monitoring of a patient’s disease and precise determination of the most appropriate degree of aggressiveness in establishing a personalized treatment plan, enabling us to focus on the secondary prevention market. Our tests routinely receive third party reimbursement, including Medicare reimbursement for up to four evaluations annually until patient stabilization.
|
Our offering provides for direct patient/physician connectivity and includes individualized treatment plans that substantially improve patient compliance and is designed to provide better clinical results.
|
|
|
